This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

ILD: Altering the Disease Course through Effective and Individualized Management

ILD: Altering the Disease Course through Effective and Individualized Management

Format

Webcast

Time to Complete

1.50 hours

Released

October 31, 2018

Expires

October 30, 2019
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM
1.50 / AANP Contact Hours

Accredited Provider

Provided by the Annenberg Center for Health Sciences at Eisenhower

Commercial Supporter

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Program Description

Steven Nathan, MD, and Imre Noth, MD, provide their insights into the challenging management of patients with an interstitial lung disease. They discuss key considerations in the diagnosis and differential diagnosis of an interstitial lung disease and the evolution in individualized treatment, including palliative care.

Content Areas

  • Pathogenesis
  • Evaluation and diagnosis
  • Nonpharmacologic and pharmacologic treatment Acute exacerbations
  • Palliative care Future directions

Intended Audience

This activity was developed for pulmonologists, rheumatologists, and other clinicians who may encounter patients with interstitial lung diseases (ILDs) and/or connective tissue diseases (CTDs).

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Diagnose interstitial lung diseases (ILDs) in a timely manner through optimal use of diagnostic criteria and radiologic findings
  • Chart disease course during the management of ILDs
  • Optimize treatment response in the management of ILDs with appropriate assessment and follow-up
  • Develop evidence-based, individualized treatment plans for ILD management

Conflict Of Interest Disclosure Policy

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Faculty

Steven D. Nathan, MD
Director, Advanced Lung Disease and Lung Transplant Programs
Inova Fairfax Hospital
Fairfax, Virginia

Dr. Nathan discloses the following:
Research Support: Boehringer Ingelheim; Roche-Genentech
Consultant: Boehringer Ingelheim; Roche-Genentech
Speakers Bureau: Boehringer Ingelheim; Roche-Genentech

Clinical area: Idiopathic pulmonary fibrosis (IPF) for all companies listed above.

Imre Noth, MD
Chief of Pulmonary & Critical Care Medicine
Professor of Medicine
University of Virginia School of Medicine
Charlottesville, Virginia

Dr. Noth discloses the following:
Consultant: Roche-Genentech; Boehringer Ingelheim; Global Blood Therapeutics; Primus Pharmaceuticals
Speakers Bureau: Roche-Genentech; Boehringer Ingelheim

Clinical area: Interstitial lung disease (ILD)/ idiopathic pulmonary fibrosis (IPF) for all companies listed above.

Publishing Staff Disclosures

Additional content planners
Gregory Scott, PharmD, RPh (medical writer) has nothing to disclose.
Barbara Yawn, MD, MSc, MSPH (peer reviewer) has nothing to disclose.
Heather Jimenez, FNP (lead nurse planner) has nothing to disclose.

Annenberg Center for Health Sciences
Charles Willis
, Director of Continuing Education, consults for Pfizer, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Annenberg Center for Health Sciences at Eisenhower designates this live meeting for a maximum of 1.50 AMA PRA Category 1 CreditsTM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.50

Type

CE for Nurse Practitioners

Accreditation Statement


Annenberg Center for Health Sciences at Eisenhower is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

Designation Statement

This program is accredited for 1.50 contact hours. Program ID #5597-EM.

Disclosure of Unlabeled Use

The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Instructions

This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications for your practice, and completing the assessment component.

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity, please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

myCME privacy policy
Add to Queue